Skip to content

Folic acid for the treatment of atropic gastritis and for cancer prevention: an extended clinical trial

Folic acid for the treatment of atropic gastritis and for cancer prevention: an extended clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-15006903
Enrollment
Unknown
Registered
2015-08-11
Start date
1994-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic Gastritis

Interventions

folic acid group:take folic acid tablet

Sponsors

Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Eligibility was restricted to those patients aged over 25 years, and with a mean atrophy score = 1.0. Thus, all participants had moderate-to-severe atrophic gastritis; the majority had intestinal metaplasia.

Exclusion criteria

Exclusion criteria: Specific exclusions included a history of cancer or of abdominal surgery; those with some serious chronic diseases such as chronic heart, lung, liver, or kidney disease; and those currently taking pills containing either ß-carotene or folic acid.

Design outcomes

Primary

MeasureTime frame
Gastroendoscopy and mucousal pathology;Cancer occurrence;

Countries

China

Contacts

Public ContactShunshi Zhu
shunshizhu2015@163.com+86 021-64156281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026